Sonova has acquired SilentCloud™, a digital application for tinnitus management, enhancing its commitment to integrated hearing care.

Information on the Target

Sonova has announced its acquisition of SilentCloud™, an innovative digital application focused on tinnitus management, which provides evidence-based treatments through user-friendly tools. This strategic acquisition is designed to support the needs of approximately 740 million individuals globally who suffer from tinnitus, a condition often associated with hearing loss, causing disturbances such as ringing or buzzing in the ears. These symptoms can significantly affect sleep, concentration, and overall quality of life.

The integration of SilentCloud™ into Sonova’s portfolio represents a significant enhancement in its commitment to delivering comprehensive hearing care. By internalizing the development of this technology, Sonova aims to fully incorporate tinnitus management within its hearing care ecosystem and expand access to this solution across new markets.

Industry Overview in the Target’s Specific Country

Sonova operates in the audiological care sector, which is gaining momentum due to an increasing prevalence of hearing-related issues globally. In recent years, the growing awareness of hearing health, coupled with an aging population, has am

View Source

Similar Deals

Galenica Labor Team Group

2025

Other Pharmaceuticals (NEC) Switzerland
Galderma Galderma shares

2025

Other Pharmaceuticals (NEC) Switzerland
Galenica Labor Team Gruppe

2025

Other Pharmaceuticals (NEC) Switzerland
Addex Therapeutics Stalicla

2025

Other Proprietary & Advanced Pharmaceuticals Switzerland
Tecan Group Wako Automation

2025

Other Biotechnology & Medical Research (NEC) Switzerland
Sandoz Just-Evotec Biologics EU SAS

2025

Other Biopharmaceuticals Switzerland

Sonova

invested in

SilentCloud™

in 2025

in a Other deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert